{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:45:15Z","timestamp":1792010715261,"version":"4.4.0"},"reference-count":108,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chemistry and Physics of Lipids"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.chemphyslip.2011.04.002","type":"journal-article","created":{"date-parts":[[2011,4,19]],"date-time":"2011-04-19T09:56:56Z","timestamp":1303207016000},"page":"515-524","source":"Crossref","is-referenced-by-count":204,"title":["Oxysterols as biomarkers in neurodegenerative diseases"],"prefix":"10.1016","volume":"164","author":[{"given":"Valerio","family":"Leoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Caccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0005","doi-asserted-by":"crossref","first-page":"12799","DOI":"10.1074\/jbc.M601019200","article-title":"24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux","volume":"281","author":"Abildayeva","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0010","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.brainresbull.2006.10.028","article-title":"Change in MRI striatal volumes as a biomarker in preclinical Huntington's disease","volume":"72","author":"Aylward","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0015","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/brain\/awg182","article-title":"Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years","volume":"126","author":"Bagnato","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0525","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1600-0404.1990.tb01563.x","article-title":"Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors","volume":"81","author":"Blennow","year":"1990","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0020","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2796.2006.01725.x","article-title":"Crossing the barrier, oxysterols as cholesterol transporters and metabolic modulators in the brain","volume":"260","author":"Bj\u00f6rkhem","year":"2006","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.mam.2009.02.001","article-title":"Oxysterols and neurodegenerative diseases","volume":"30","author":"Bj\u00f6rkhem","year":"2009","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0030","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1194\/jlr.R006338","article-title":"Genetic connections between neurological disorders and cholesterol metabolism","volume":"51","author":"Bj\u00f6rkhem","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0035","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1161\/01.ATV.0000120374.59826.1b","article-title":"Brain cholesterol: long secret life behind a barrier","volume":"24","author":"Bj\u00f6rkhem","year":"2004","journal-title":"Arterioscl. Thromb. Vasc. Biol."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"Blennow","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0045","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02815140","article-title":"Tau protein in cerebrospinal fluid, a biochemical marker for axonal degeneration in Alzheimer disease?","volume":"26","author":"Blennow","year":"1995","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0055","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1074\/jbc.271.8.4436","article-title":"Cholesterol modulates \u03b1-secretase cleavage of amyloid precursor protein","volume":"271","author":"Bodovitz","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(01)02277-7","article-title":"On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells","volume":"314","author":"Bogdanovic","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0065","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0022-2275(20)32393-2","article-title":"Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface","volume":"41","author":"Bretillon","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0070","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-3940(00)01466-X","article-title":"Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases","volume":"293","author":"Bretillon","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0075","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mam.2009.02.005","article-title":"Oxysterols, sources, cellular storage and metabolism, and new insights into their roles in cholesterol homeostasis","volume":"30","author":"Brown","year":"2009","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0080","doi-asserted-by":"crossref","first-page":"34674","DOI":"10.1074\/jbc.M402324200","article-title":"Differential expression of cholesterol hydroxylases in Alzheimer's disease","volume":"279","author":"Brown","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0085","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrn2620","article-title":"Apolipoprotein E and its receptors in Alzheimer's disease, pathways, pathogenesis and therapy","volume":"10","author":"Bu","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0090","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/brain\/awl269","article-title":"CSF phosphorylated Tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease","volume":"129","author":"Buerger","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.atherosclerosis.2006.09.026","article-title":"Lipoprotein distribution and biological variation of 24S- and 27-hydroxycholesterol in healthy volunteers","volume":"194","author":"Burkard","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0100","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ana.10326","article-title":"Thalamic neurodegeneration in multiple sclerosis","volume":"52","author":"Cifelli","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0105","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.clineuro.2005.07.010","article-title":"Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis","volume":"108","author":"Danylait\u00e9 Karrenbauer","year":"2006","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0110","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","article-title":"Thematic review series, brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal","volume":"45","author":"Dietschy","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0115","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbrc.2007.05.033","article-title":"Regulation of \u03b1-and \u03b2-secretase activity by oxysterols: cerebrosterol stimulates processing of APP via the \u03b1-secretase pathway","volume":"359","author":"Famer","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0120","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1212\/WNL.52.8.1687","article-title":"Correlation between rates of brain atrophy and cognitive decline in AD","volume":"52","author":"Fox","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0125","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/00001756-199906030-00014","article-title":"The role of cholesterol in the biosynthesis of beta-amyloid","volume":"10","author":"Frears","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0130","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/jmg.2009.066399","article-title":"Wild-type but not mutant huntingtin modulates the transcriptional activity of liver X receptors","volume":"46","author":"Futter","year":"2009","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0135","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1326-4-13","article-title":"The role of Tau in neurodegeneration","volume":"4","author":"Gendron","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0140","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","article-title":"Mechanisms of neurodegeneration in Huntington's disease","volume":"27","author":"Gil","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0145","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/brain\/awp073","article-title":"CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5","volume":"132","author":"Goizet","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0155","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1194\/jlr.M300320-JLR200","article-title":"Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease","volume":"45","author":"Heverin","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0160","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1194\/jlr.M500024-JLR200","article-title":"Crossing the barrier, net flux of 27-hydroxycholesterol into the human brain","volume":"46","author":"Heverin","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0165","doi-asserted-by":"crossref","first-page":"16576","DOI":"10.1074\/jbc.273.26.16576","article-title":"Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol","volume":"273","author":"Howland","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0530","doi-asserted-by":"crossref","first-page":"8838","DOI":"10.1073\/pnas.151254698","article-title":"Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons","volume":"98","author":"Huang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0170","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3233\/JAD-2010-100780","article-title":"Vitamin E and enzymatic\/oxidative stress-driven oxysterols in amnestic mild cognitive impairment subtypes and Alzheimer's disease","volume":"21","author":"Iuliano","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0175","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0180","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/awp062","article-title":"Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease, implications for sequence of pathological events in Alzheimer's disease","volume":"132","author":"Jack","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0185","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1212\/WNL.51.4.993","article-title":"Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease","volume":"51","author":"Jack","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0190","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1212\/WNL.40.2.229","article-title":"Heterogenity of blood\u2013brain barrier changes in multiple sclerosis, an MRI study with gadolinium-DTPA enhancement","volume":"40","author":"Kermode","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0195","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1074\/jbc.M607831200","article-title":"Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to Apoliporptien E discs and suppression of amyloid-beta peptide generation","volume":"282","author":"Kim","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0200","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-0404.2006.00685.x","article-title":"Cholesterol as a risk factor for Alzheimer's disease\u2014epidemiological evidence","volume":"185","author":"Kivipelto","year":"2006","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0205","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.neulet.2004.07.031","article-title":"Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients","volume":"368","author":"Kolsch","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0210","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.neurobiolaging.2007.10.010","article-title":"Serum 24S-hydroxycholesterol and hippocampal size in middle-aged normal individuals","volume":"30","author":"Koschack","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0215","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1073\/pnas.0600316103","article-title":"Brain cholesterol turnover required for geranylgeraniol production and learning in mice","volume":"103","author":"Kotti","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0220","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1096\/fj.00-0815fje","article-title":"Essential role for cholesterol in synaptic plasticity and neuronal degeneration","volume":"15","author":"Koudinov","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0225","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/brain\/122.7.1261","article-title":"Spatial mapping of T2 and gadolinium-enhancing T1 lesion volumes in multiple sclerosis, evidence for distinct mechanism of lesion genesis?","volume":"122","author":"Lee","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0230","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1194\/jlr.C400005-JLR200","article-title":"Levels of 7-oxocholesterol in cerebrospinal fluid in patients with multiple sclerosis are more than a thousand times lower than reported","volume":"46","author":"Leoni","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0235","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/brain\/awn212","article-title":"Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease","volume":"131","author":"Leoni","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0240","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0304-3940(02)00887-X","article-title":"Changes in human plasma levels of 24S-hydroxycholesterol during progression of multiple sclerosis","volume":"331","author":"Leoni","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0245","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1194\/jlr.M200434-JLR200","article-title":"Side-chain oxidised oxysterols in cerebrospinal fluid and integrity of blood\u2013brain barrier","volume":"44","author":"Leoni","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0250","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1515\/CCLM.2004.034","article-title":"Diagnostic use of cerebral and extracerebral oxysterols","volume":"42","author":"Leoni","year":"2004","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0255","unstructured":"Leoni, V., 2005b. On the Possible use of oxysterols for the diagnosis and evaluation of patients with neurological and neurodegenerative diseases. Karolinska Institutet, Stockholm. ISBN 91-7140-255-1."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0260","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neulet.2005.11.046","article-title":"Are the CSF levels of 24S-hydroxycholesterol a sensitive biomarker for mild cognitive impairment?","volume":"397","author":"Leoni","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0265","first-page":"21","article-title":"Whole body cholesterol metabolism is impaired in Huntington's disease","author":"Leoni","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0270","doi-asserted-by":"crossref","first-page":"13266","DOI":"10.1073\/pnas.95.22.13266","article-title":"Amyloid beta peptide alters intracellular vesicle trafficking and cholesterol homeostasis","volume":"95","author":"Liu","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0275","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1073\/pnas.96.13.7238","article-title":"cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain","volume":"6","author":"Lund","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0280","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.1073\/pnas.93.18.9799","article-title":"Cholesterol homeostasis in human brain, evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation","volume":"93","author":"L\u00fctjohann","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0285","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-2275(20)32052-6","article-title":"Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients","volume":"41","author":"L\u00fctjohann","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0290","article-title":"Upregulation of brain renin angiotensin system by 27-hydroxycholesterol in Alzheimer's disease","volume":"February","author":"Mateos","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0295","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0300","first-page":"CD007514","article-title":"Statins for the treatment of dementia","volume":"8","author":"McGuinness","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0535","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1194\/jlr.M600529-JLR200","article-title":"Novel route for elimination of brain oxysterols across the blood-brain barrier: conversion into 7alpha-hydroxy-3-oxo-4-cholestenoic acid","volume":"48","author":"Meaney","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0305","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/brain\/awf177","article-title":"Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance","volume":"125","author":"Miller","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0310","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1523\/JNEUROSCI.0862-09.2009","article-title":"Increased membrane cholesterol might render ature hippocampal neurons more suceptable to B-amyloid-induced calpain activation and Tau toxicity","volume":"29","author":"Nicholson","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0315","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0320","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1074\/jbc.M505179200","article-title":"Studies on the transcriptional regulation of cholesterol 24-hydroxylase (CYP46A1): marked insensitivity toward different regulatory axes","volume":"281","author":"Ohyama","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0325","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-3956(01)00050-4","article-title":"24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia","volume":"36","author":"Papassotiropoulos","year":"2002","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0330","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1097\/00001756-200006260-00030","article-title":"Plasma 24S-hydroxycholesterol, a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease","volume":"11","author":"Papassotiropoulos","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0335","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","article-title":"Detection of Huntington's disease decades before diagnosis, the Predict-HD study","volume":"79","author":"Paulsen","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0345","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/bies.10195","article-title":"Outsourcing in the brain, do neurons depend on cholesterol delivery by astrocytes?","volume":"25","author":"Pfrieger","year":"2003","journal-title":"Bioessays"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0350","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2217\/17460875.3.5.505","article-title":"Apolipoprotein E and cholesterol in aging and disease in the brain","volume":"3","author":"Posse de Chaves","year":"2008","journal-title":"Future Lipidol."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-4-1","article-title":"Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on beta-amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells","volume":"4","author":"Prasanthi","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0360","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nn0403-345","article-title":"Alzheimer's disease: the cholesterol connection","volume":"6","author":"Puglielli","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0365","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1212\/WNL.58.5.695","article-title":"Regional and progressive thinning of the cortical ribbon in Huntington's disease","volume":"58","author":"Rosas","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0370","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","article-title":"The enzymes, regulation, and genetics of bile acid synthesis","volume":"72","author":"Russell","year":"2003","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0375","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1146\/annurev.biochem.78.072407.103859","article-title":"Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain","volume":"78","author":"Russell","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0380","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","article-title":"Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease","volume":"43","author":"Saunders","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0385","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0304-3940(02)00164-7","article-title":"Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls","volume":"324","author":"Sch\u00f6nknecht","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0390","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10048-008-0158-9","article-title":"Analysis of CYP7B1 in non-consanguineous cases of hereditary spastic paraplegia","volume":"10","author":"Sch\u00fcle","year":"2009","journal-title":"Neurogenetics"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0395","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1194\/jlr.M002543","article-title":"Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis","volume":"51","author":"Sch\u00fcle","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0400","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/WAD.0b013e3181d61fea","article-title":"Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkers","volume":"24","author":"Serrano-Pozo","year":"2010","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0405","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neulet.2007.08.014","article-title":"Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxycholesterol in patients with cognitive disorders","volume":"425","author":"Shafaati","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0410","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1073\/pnas.95.11.6460","article-title":"Cholesterol depletion inhibits the generation of b-amyloid in hippocampal neurons","volume":"95","author":"Simons","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0415","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neulet.2009.06.073","article-title":"Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease","volume":"462","author":"Solomon","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0540","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/exnr.1994.1019","article-title":"Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype","volume":"125","author":"Strittmatter","year":"1994","journal-title":"Exp Neurol"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0420","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","article-title":"Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study, cross-sectional analysis of baseline data","volume":"8","author":"Tabrizi","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0425","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0304-3940(03)00667-0","article-title":"Decreased levels of the brain specific 24S-hydroxycholesterol and cholesterol precursors in serum of multiple sclerosis patients","volume":"347","author":"Teunissen","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0430","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/jnr.21266","article-title":"24S-hydroxycholesterol in relation to disease manifestation of acute experimental autoimmune encephalomyelitis","volume":"85","author":"Teunissen","year":"2007","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0435","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1212\/WNL.47.6.1469","article-title":"Accumulation of hypointense lesions (\u201cblack holes\u201d) on T1 spin-echo MRI correlates with disease progression in multiple sclerosis","volume":"47","author":"Truyen","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0440","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ajhg.2007.10.001","article-title":"Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration","volume":"82","author":"Tsaousidou","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0445","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1093\/hmg\/ddm170","article-title":"Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation","volume":"16","author":"Valenza","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0450","doi-asserted-by":"crossref","first-page":"10844","DOI":"10.1523\/JNEUROSCI.0917-10.2010","article-title":"Cholesterol defect is marked across multiple rodent models of Huntington's disease and is manifest in astrocytes","volume":"30","author":"Valenza","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0455","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.nbd.2007.07.004","article-title":"Progressive dysfunction of the cholesterol biosynthesis pathway in the R6\/2 mouse model of Huntington's disease","volume":"28","author":"Valenza","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0460","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","article-title":"Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease","volume":"25","author":"Valenza","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0465","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.neurobiolaging.2007.08.005","article-title":"Total cholesterol and oxysterols: early markers for cognitive decline in elderly?","volume":"30","author":"van den Kommer","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0470","first-page":"675","article-title":"Patterns of lesion development in multiple sclerosis, longitudinal observations with T1-weighted spin-echo and magnetization transfer MR","volume":"19","author":"van Waesberghe","year":"1998","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0475","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1212\/WNL.50.5.1282","article-title":"Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis","volume":"50","author":"van Walderveen","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0480","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1021\/bi602407r","article-title":"The C-terminal lipid-binding domain of apolipoprotein E is a highly efficient mediator of ABCA1-dependent cholesterol efflux that promotes the assembly of high-density lipoproteins","volume":"46","author":"Vedhachalam","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0545","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/1567205043480546","article-title":"The effects of gender and CYP46 and apo E polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients treated with statins","volume":"1","author":"Vega","year":"2004","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0485","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1212\/WNL.0b013e3181af79e5","article-title":"Alzheimer's disease neuroimaging initiative. MRI and CSF biomarkers in normal, MCI, and AD subjects, diagnostic discrimination and cognitive correlations","volume":"73","author":"Vemuri","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0490","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0495","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntingto\u0144s disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0500","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1096\/fj.07-9944com","article-title":"ATP-binding cassette transporters G1 and G4 mediate cholesterol and desmosterol efflux to HDL and regulate sterol accumulation in the brain","volume":"22","author":"Wang","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0505","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/archneurol.2010.199","article-title":"3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of central nervous system diseases","volume":"67","author":"Willey","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0510","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","article-title":"Decreased prevalence of Alzheimer's disease associated with HMG CoA reductase inhibitors","volume":"57","author":"Wolozin","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0515","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1194\/jlr.M300164-JLR200","article-title":"Quantification of two pathways for cholesterol excretion from the brain in normal mice and mice with neurodegeneration","volume":"44","author":"Xie","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0550","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0306-4522(03)00438-X","article-title":"Dehydroepiandrosterone 7-hydroxylase CYP7B1: predominant expression in primate hippocampus and reduced expression in Alzheimer's disease","volume":"121","author":"Yau","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.chemphyslip.2011.04.002_bib0520","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev.med.56.082103.104739","article-title":"Role of magnetic resonance imaging and immunotherapy in treating multiple sclerosis","volume":"56","author":"Zhang","year":"2005","journal-title":"Annu. Rev. Med."}],"container-title":["Chemistry and Physics of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009308411000430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009308411000430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T21:53:14Z","timestamp":1637531594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009308411000430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":108,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0009308411000430"],"URL":"https:\/\/doi.org\/10.1016\/j.chemphyslip.2011.04.002","relation":{},"ISSN":["0009-3084"],"issn-type":[{"value":"0009-3084","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}